Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

ARTELO BIOSCIENCES, INC.

CIK 1621221 ARTL·Pharmaceutical Preparations · All EDGAR filings ↗

Accounting standard newly cited Filing comparison

ARTELO BIOSCIENCES, INC. cited accounting standard ASU 2023-08 for the first time in this filing series

New Accounting Standard Adopted During the year ended December 31, 2025, the Company adopted ASU 2023-08, Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets (“ASU 2023-08”).
Evidence
Adopted
2023-08
Adoption year stated
2025
Contexts
New Accounting Standard Adopted During the year ended December 31, 2025, the Company adopted ASU 2023-08, Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets (“ASU 2023-08”).
New standards
2023-08
Prior filed
2025-03-03
Prior form
10-K
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.